MIRM 8-K 2026-01-12

Mirum Pharmaceuticals, Inc. (MIRM) 8-K dated 2026-01-12 — accession 0001759425-26-000004. This URL is the filing, not the MIRM hub.

Mirum Pharmaceuticals, Inc. (MIRM) is a biotechnology company listed on NASDAQ.

Mirum Pharmaceuticals, Inc. filed a 8-K on 2026-01-12. Accession 0001759425-26-000004.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.

Not investment advice. The MIRM SEC hub lists recent forms. The stock page is the research view.